Variables | non-RP group (N = 71) | RP group (N = 29) | p | |
---|---|---|---|---|
Gender | Male | 60(84.5) | 27(93.1) | 0.405 |
 | Female | 11(15.5) | 2(6.9) |  |
Age | ≤ 60 | 33(46.5) | 13(44.8) | 0.880 |
 | >60 | 38(53.5) | 16(55.2) |  |
Smoking status | Never | 18(25.4) | 7(24.1) | 0.899 |
 | Former/current | 53(74.6) | 22(75.9) |  |
Tumor location | Right Lung | 38(53.5) | 16(55.2) | 1.000 |
 | Left Lung | 31(43.7) | 12(41.4) |  |
 | Others | 2(2.8) | 1(3.4) |  |
Histology | ADC | 28(39.4) | 6(20.7) | 0.073 |
 | SCC | 43(60.6) | 23(79.3) |  |
Clinical stage | IIIA | 32(45.1) | 10(34.5) | 0.260 |
 | IIIB | 34(47.9) | 14(48.3) |  |
 | IIIC | 5(7.0) | 5(17.2) |  |
Radiation dose | ≥60 Gy | 57(80.3) | 21(72.4) | 0.389 |
 | ≤ 60 Gy | 14(19.7) | 8(27.6) |  |
Chemoradiotherapy | SCRT | 30(42.3) | 15(51.7) | 0.388 |
 | CCRT | 41(57.7) | 14(48.3) |  |
Radiation therapy | 3D-CRT | 15(21.1) | 9(31.0) | 0.292 |
 | IMRT | 56(78.9) | 20(69.0) |  |